Post #3917532

Most recent #CDC dataset, updated Monday, again omits Nowcast for the most recent four-week period, "[d]ue to low numbers of sequences being reported to CDC". For May-June reporting, XFG.23.1.3 / RV family appears to gain share among Stratus XFG family. Stratus-Eleventy XFG.1.1, now appears to be in retreat. Overall, XFG fam, the sole representative of the FDA-Vaccine-Target LP.8.1 lineage, continue to hold about two thirds share. Nimbus NB.1.8.2 / PQ family appears to lose ground, as LF.7 family holds firm, under pressure from Cicada BA.3.2, and a troubling "Other" category that has exploded into prominence in the latest round of reporting. Note that, in absence of robust data from states, CDC has given up modeling historical estimates, instead giving only "empiric" shares of reported sequences. Raj's dashboard, updated end of March, showed XFG.1.1 at a quarter share, for the last half of the most recent reporting period, while Cicada grandkid RE.2 made a significant appearance. That said, said GISAID data was dominated by paltry submissions from New York (171), Minnesota (85), Maryland (84), Nebraska (53), and Arizona (17). ❖ #ThisIsOurPolio #variants #CovidIsNotOver #dataviz #datavis